StockData
Fortress Biotech, Inc. logo

Fortress Biotech, Inc. (FBIO) stock

FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$1.82+0.11 (+6.43%)

Close on Nov 17, 2026Market cap $66.94MP/E –Yield –

Fortress Biotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Fortress Biotech's revenue for the twelve months ending Jun 30, 2026 was $68.47M, up 15.5% year over year. For fiscal 2025 it was $63.26M, up 9.7% from the year before. Over ten years it grew 53.6% a year on average. The highest annual figure on record is $84.51M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$63.26M+9.7%
FY2024Dec 31, 2024$57.68M-31.8%
FY2023Dec 31, 2023$84.51M+11.6%
FY2022Dec 31, 2022$75.74M+10.1%
FY2021Dec 31, 2021$68.79M+50.9%
FY2020Dec 31, 2020$45.60M+24.5%
FY2019Dec 31, 2019$36.63M+36.3%
FY2018Dec 31, 2018$26.88M+55.9%
FY2017Dec 31, 2017$17.25M+4.6%
FY2016Dec 31, 2016$16.48M+1809.6%
FY2015Dec 31, 2015$863.00K–
FY2014Dec 31, 2014$0–
FY2013Dec 31, 2013$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.72M+14.0%
Q1 FY2026Mar 31, 2026$16.04M+22.1%
Q4 FY2025Dec 31, 2025$16.08M+6.3%
Q3 FY2025Sep 30, 2025$17.63M+20.5%
Q2 FY2025Jun 30, 2025$16.41M+10.2%
Q1 FY2025Mar 31, 2025$13.14M+0.8%
Q4 FY2024Dec 31, 2024$15.12M-24.2%
Q3 FY2024Sep 30, 2024$14.63M-57.9%
Q2 FY2024Jun 30, 2024$14.90M-14.3%
Q1 FY2024Mar 31, 2024$13.03M+4.8%
Q4 FY2023Dec 31, 2023$19.95M+21.6%
Q3 FY2023Sep 30, 2023$34.75M+110.3%
Q2 FY2023Jun 30, 2023$17.39M-7.9%
Q1 FY2023Mar 31, 2023$12.43M-48.1%
Q4 FY2022Dec 31, 2022$16.40M-10.2%
Q3 FY2022Sep 30, 2022$16.53M-21.6%
Q2 FY2022Jun 30, 2022$18.89M+5.8%
Q1 FY2022Mar 31, 2022$23.93M+106.5%
Q4 FY2021Dec 31, 2021$18.28M+32.9%
Q3 FY2021Sep 30, 2021$21.09M+122.5%
Q2 FY2021Jun 30, 2021$17.84M+88.7%
Q1 FY2021Mar 31, 2021$11.59M-10.3%
Q4 FY2020Dec 31, 2020$13.75M+23.5%
Q3 FY2020Sep 30, 2020$9.48M-3.0%
Q2 FY2020Jun 30, 2020$9.46M+2.2%
Q1 FY2020Mar 31, 2020$12.92M+99.4%
Q4 FY2019Dec 31, 2019$11.13M+23.8%
Q3 FY2019Sep 30, 2019$9.77M+88.9%
Q2 FY2019Jun 30, 2019$9.25M+35.7%
Q1 FY2019Mar 31, 2019$6.48M+9.7%
Q4 FY2018Dec 31, 2018$8.99M+19.2%
Q3 FY2018Sep 30, 2018$5.17M+105.3%
Q2 FY2018Jun 30, 2018$6.82M+54.7%
Q1 FY2018Mar 31, 2018$5.90M+112.5%
Q4 FY2017Dec 31, 2017$7.54M-47.6%
Q3 FY2017Sep 30, 2017$2.52M+158.5%
Q2 FY2017Jun 30, 2017$4.40M–
Q1 FY2017Mar 31, 2017$2.78M–
Q4 FY2016Dec 31, 2016$14.41M–
Q3 FY2016Sep 30, 2016$975.00K–

More Fortress Biotech figures

See a number that looks wrong?